Auralgan: Impurities out of specification
Last updated
Summary
Product
Auralgan
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Auralgan | Auralgan | DIN 02332477 | Solution | Antipyrine 54mg/ml, Benzocaine 14mg/ml | 20A18, 20B03, 20C09, 20N14, 21C27 |
Issue
| Impurities could be out of specification in affected lots. |
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Paladin Labs Inc. Montréal, QC H4M 2P2 |
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type II
Identification number
RA-63889
Get notified
Receive notifications for new and updated recalls and alerts by category.